Applied Molecular Transport Inc. (AMTI): Price and Financial Metrics

Applied Molecular Transport Inc. (AMTI): $0.26

0.04 (-14.30%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add AMTI to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#246 of 407

in industry

AMTI Price/Volume Stats

Current price $0.26 52-week high $0.84
Prev. close $0.31 52-week low $0.13
Day low $0.26 Volume 240,400
Day high $0.31 Avg. volume 470,969
50-day MA $0.18 Dividend yield N/A
200-day MA $0.25 Market Cap 10.87M

AMTI Stock Price Chart Interactive Chart >


Applied Molecular Transport Inc. (AMTI) Company Bio


Applied Molecular Transport, Inc. is a clinical-stage biopharmaceutical company, which engages in the design and development of a pipeline of novel oral biologic product candidates for the treatment of autoimmune, inflammatory, and metabolic diseases. The company was founded by Tahir Mahmood and Randall J. Mrsny on November 21, 2016 and is headquartered in South San Francisco, CA.


AMTI Latest News Stream


Event/Time News Detail
Loading, please wait...

AMTI Latest Social Stream


Loading social stream, please wait...

View Full AMTI Social Stream

Latest AMTI News From Around the Web

Below are the latest news stories about APPLIED MOLECULAR TRANSPORT INC that investors may wish to consider to help them evaluate AMTI as an investment opportunity.

Applied Molecular Transport Insider Ups Holding By 239% During Year

Looking at Applied Molecular Transport Inc.'s ( NASDAQ:AMTI ) insider transactions over the last year, we can see that...

Yahoo | November 22, 2023

Applied Molecular Transport Reports Third Quarter 2023 Financial Results

Company Entered into Definitive Merger Agreement with Cyclo Therapeutics Cash and Cash Equivalents of $18.1 million, as of September 30, 2023 SOUTH SAN FRANCISCO, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a biopharmaceutical company, today reported financial results for the third quarter ended September 30, 2023. Recent Business Highlights and Anticipated Milestones Entered into a definitive merger agreement with Cyclo Therapeutics Combined

Yahoo | November 9, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Pre-market stock movers are a hot topic this morning and we're checking on the biggest ones investors will want to watch on Friday!

William White on InvestorPlace | September 22, 2023

Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement

GAINESVILLE, Fla. & SOUTH SAN FRANCISCO, Calif., September 21, 2023--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company focused on developing transformative therapies for rare and neurological diseases with limited treatment options, and Applied Molecular Transport Inc. (Nasdaq: AMTI) ("AMT"), a biopharmaceutical company, announced today that the companies have entered into a definitive agreement (the Merger Agreement) pursuant

Yahoo | September 21, 2023

Applied Molecular Transport Reports Second Quarter 2023 Financial Results

Currently Pursuing Strategic Alternatives, with MTS Health Partners, L.P. Advising the Company Cash and Cash Equivalents of $22.5 million, as of June 30, 2023 SOUTH SAN FRANCISCO, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2023. Financial Results for the Second Quarter Ended June 30, 2023 Research and development (R&D) expenses. Total R&D expen

Yahoo | August 14, 2023

Read More 'AMTI' Stories Here

AMTI Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year -16.29%
3-year -99.24%
5-year N/A
YTD N/A
2023 0.00%
2022 -97.00%
2021 -54.57%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!